US · Healthcare

Acurx Pharmaceuticals LLC (ACXP)

Biotechnology

Acurx Pharmaceuticals LLC (ACXP) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for ACXP

P/E ratio

25.00

Acurx Pharmaceuticals LLC (ACXP) — FAQ

What is ACXP's P/E ratio?

The price-to-earnings (P/E) ratio for Acurx Pharmaceuticals LLC (ACXP) is 25.00 (data as of 2026-05-23).

Does Acurx Pharmaceuticals LLC pay a dividend?

Dividend yield is not available in the current snapshot for Acurx Pharmaceuticals LLC (ACXP). Check the MyAverix Finance app for the latest dividend data.

What sector is Acurx Pharmaceuticals LLC in?

Acurx Pharmaceuticals LLC (ACXP) is classified in the Healthcare sector (Biotechnology industry).

What exchange is ACXP listed on?

ACXP is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)